This Biotech’s Nasdaq Uplisting Opens the Door to Rapid Expansion

A Nasdaq uplist. A $4M boost. And a biotech eyeing global growth.

There’s a reason why Palantir only partners with serious operators.

Their software is used by the U.S. military, intelligence agencies, and Fortune 500s.

So when they announce a strategic collaboration in the autonomous robotics space, it’s worth watching closely.

Their newest partner?

A company with more than 4 million hours of autonomous fieldwork.

Real deployments. Real data. Real revenue.

This means faster incident detection.  Smarter machine learning.

And the kind of predictive security that could transform cities, campuses, and corporations.

This isn’t a beta test.  This is live and expanding.

And while the market sleeps, early investors may have a limited window to act.

Don’t wait for the headlines.

See what Palantir already knows.  Subscribe today.

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

U.S. stocks were mixed today as investors wavered between optimism from strong retail sales and earnings and caution ahead of the Zelensky–Trump peace talks and Fed Chair Jerome Powell’s upcoming Jackson Hole speech.

Amphenol (NYSE: APH) has agreed to acquire Trexon, a specialist in connectivity and cable assemblies, for approximately $1 billion in cash, marking its second major deal in just weeks.

The move strengthens Amphenol’s presence in the defense and aerospace sectors, while broadening its portfolio to include high-reliability connectors and cable solutions.

For investors, the acquisition underlines how Amphenol is aligning its growth strategy with defense spending cycles.

Trexon’s focus on military and mission-critical connectivity complements Amphenol’s scale and global reach, creating opportunities to capture a larger share of government contracts at a time when geopolitical tensions are driving higher defense budgets.

The timing also suggests that Amphenol is balancing its bets.

While its recent $10.5 billion deal for CommScope’s cable unit targeted AI-driven data infrastructure, this smaller but strategic acquisition brings resilience through defense exposure.

That diversification could help cushion volatility across markets and signal to shareholders that management is thinking in decades, not just quarters.

As the deal progresses toward a planned close in late 2025, investors will closely monitor integration updates and the speed at which Trexon’s capabilities can be integrated into Amphenol’s defense offerings.

If the execution holds, this buyout may serve as a template for how Amphenol integrates bolt-on acquisitions into its broader growth strategy.

Timing is everything in the market — and these five stocks could be poised for a major move.

Each has been highlighted in a brand-new special report available today.

Similar research has uncovered stocks that went on to deliver eye-popping gains.

Don’t wait until it’s too late to see what’s inside.

The clock runs out tonight.

[Unlock the Free Report Now]

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

BlackRock (NYSE: BLK), through its Global Infrastructure Partners arm, has acquired a 49.99% stake in Eni’s carbon capture and storage (CCS) subsidiary, underscoring the asset manager’s growing interest in large-scale decarbonization infrastructure.

The newly formed entity, Eni CCUS Holding, oversees projects in the UK, Netherlands, and Italy, with further expansion under review.

For investors, this deal highlights how BlackRock is positioning itself at the intersection of energy transition financing and long-horizon infrastructure returns.

CCS remains one of the most capital-intensive but politically supported technologies in Europe, and by entering as a minority partner, BlackRock captures exposure to regulated, fee-based cash flows without assuming full project execution risk.

The move also signals that the firm sees growing institutional demand for decarbonization-linked assets, which could eventually support the launch of new funds or vehicles marketed directly to clients seeking sustainable yield.

The move places BlackRock in direct competition with sovereign funds and private equity players also circling industrial decarbonisation opportunities, giving its shareholders a front-row seat in one of the fastest-growing segments of climate infrastructure.

Those considering entry into BlackRock stock should note how these partnerships complement its traditional asset management revenues, adding a pipeline of hard-asset income streams that can help smooth volatility across economic cycles.

The coming quarters will reveal whether the CCS portfolio can scale fast enough to make a material impact on long-term earnings.

Our team has just finished reviewing over 4,000 stocks — and only seven made the final cut.

These picks are based on one thing: potential for strong performance in the next 30 days.

While past performance can’t guarantee future gains, this strategy has historically averaged double the S&P’s return.

If you’re looking for short-term upside built on real earnings data, don’t trade without seeing this list.

[Claim Your Free Copy Here]

The recent volatility in Whirlpool (NYSE: WHR) has sent a clear message to the market, but it appears to be one that is being misinterpreted.

While the company faces short-term headwinds, a confluence of strategic advantages and technical signals suggests its stock is at a critical inflection point, presenting a unique risk-reward scenario for discerning investors.

The narrative of weakness, fueled by a dividend cut and fluctuating tariffs, overshadows the company's powerful long-term catalysts.

With over 80% of its manufacturing footprint located domestically, Whirlpool is exceptionally well-positioned to benefit from the current high-tariff environment, gaining a significant pricing advantage over international competitors.

Furthermore, the dividend cut, a move that often spooks investors, is a strategic reset that allows the company to strengthen its financial position for future growth.

Perhaps the most compelling dynamic is the relationship between institutional ownership and short interest.

Institutions have been buying aggressively, owning over 90% of the stock, even as short sellers have been piling in, pushing short interest to a long-term high of 21%.

With the stock price near a potential bottom and supported by a robust balance sheet, the narrative for Whirlpool has shifted.

It is no longer a story of weakness, but one of a strategically positioned company ready to capitalize on a long-awaited housing market recovery.

👉 Click here to get our closing report to your cell for free!

Propanc Biopharma Inc [PPCB] $5.85 (+103.83%)

Propanc Biopharma surged after uplisting from OTC Pink to Nasdaq, supported by a $4 million offering that boosts working capital.

Soligenix Inc [SNGX] $4.95 (+78.41%)

Soligenix jumped after the FDA granted orphan drug designation to its experimental therapy dusquetide for Behçet’s Disease, unlocking incentives like market exclusivity and trial funding.

GoodRx Holdings Inc [GDRX] $5.12 (+37.13%)

GoodRx soared after securing a partnership with Novo Nordisk to offer Ozempic and Wegovy at $499 per month, greatly expanding patient access to the in-demand GLP-1 treatments.

Vyome Holdings Inc [HIND] $8.73 (-37.64%)

Vyome fell after announcing a strategic review of its Livechain subsidiary, raising uncertainty about the company’s direction.

Tonix Pharm Holdings [TNXP] $40.07 (-21.78%)

Tonix slumped despite FDA approval of its fibromyalgia treatment, as investors locked in profits after Friday’s surge.

Thumzup Media Corp [TZUP] $8.50 (-14.57%)

Thumzup declined after reporting a wider second-quarter net loss of $1.19 million, reflecting rising costs and ongoing profitability challenges.

Palantir just made a move that could reshape the future of physical security.

They’ve teamed up with an autonomous robotics firm that’s already logging millions of operational hours across the United States.

Hospitals. Law enforcement. Government buildings.

This is not a startup hoping to go live.

It’s a company with contracts, cash flow, and now, Palantir-level support to back it up.

The new partnership enables a data fusion that makes traditional surveillance systems look ancient.

AI is not just watching. It’s learning, predicting, and responding.

And with Palantir in the mix, the infrastructure to scale this system is now in place - especially at the Federal level.

This could be one of the most overlooked AI investments in the market right now.

The story is just starting.  Get ahead of it while you still can.

Unlock the name and symbol of this trending company now by subscribing.

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.